Thompson Davis & Co’s NEVRO CORP. NVRO Stock Holding History

Thompson Davis & Co’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-120	Closed	-$11K	–	1118
2017 Q3	$11K	Buy	120 +3	+3%	+$257	0.02%	674
2017 Q2	$9K	Hold	117	–	–	0.01%	703
2017 Q1	$11K	Hold	117	–	–	0.02%	672
2016 Q4	$9K	Buy	+117	New	+$10K	0.01%	738

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Thompson Davis & Co's NVRO Position: Q4 2017 in Review

Thompson Davis & Co sold out of NEVRO CORP. (NVRO) in Q4 2017, closing a stake of 120 shares — an estimated $11K sold.

Thompson Davis & Co first reported a position in NVRO in Q4 2016 and held it in 4 quarters. The position peaked at $11K in Q3 2017. 194 funds tracked by Wall St. Rank hold NVRO as of Q4 2017.

Thompson Davis & Co reported no remaining NEVRO CORP. position as of Q4 2017 after selling out during the quarter.
Thompson Davis & Co sold 120 NEVRO CORP. shares in Q4 2017, an estimated $11K.
Thompson Davis & Co first reported a position in NEVRO CORP. in Q4 2016 and held it in 4 quarters.
Thompson Davis & Co's NEVRO CORP. position peaked at $11K in Q3 2017.
194 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.